Topping tamoxifen as 1st-line Rx for postmenopausal breast Ca

February 1, 2005

Aromatase inhibitors should replace tamoxifen as the first choice for preventing recurrence of breast cancer in postmenopausal women with localized hormone receptor-positive disease, according to this large-scale study.